Suraksha Diagnostic Limited
Promoter holding in Suraksha Diagnostic Limited was 49.10% in Sep 2026, unchanged from the previous quarter. Since Dec 2024 it has risen 0.32 points.
By quarter
Quarter by quarter
| Quarter | Promoters | Public |
|---|---|---|
| Sep '26 | 49.10%=0.00 | 50.90%=0.00 |
| Jun '26 | 49.10%=0.00 | 50.90%=0.00 |
| Mar '26 | 49.10%▲0.10 | 50.90%▼0.10 |
| Dec '25 | 49.00%▲0.02 | 51.00%▼0.02 |
| Sep '25 | 48.98%▲0.10 | 51.02%▼0.10 |
| Jun '25 | 48.88%▲0.10 | 51.12%▼0.10 |
| Mar '25 | 48.78%=0.00 | 51.22%=0.00 |
| Dec '24 | 48.78%=0.00 | 51.22%=0.00 |
Trend
- Over a longer period, promoter holding went from 48.78% in Sep 2024 to 49.10% in Sep 2026, up 0.32 points.
- Of the last 8 quarterly changes on record, promoter holding rose in 4 and stayed the same in 4.
- The largest quarterly change was a rise of 0.10 points in the quarter to Mar 2026.
Compared with similar companies
Promoter holding in Suraksha Diagnostic Limited is lower than 66% of companies in the Healthcare sector in India.
| Company | Promoters |
|---|---|
| Suraksha Diagnostic Limited | 49.10% |
| Tarsons Products Limited | 47.30% |
| Krsnaa Diagnostics Limited | 27.11% |
| NGL Fine-Chem Limited | 72.49% |
| Amrutanjan Health Care Limited | 46.52% |
| Jagsonpal Pharmaceuticals Limited | 69.05% |
Similar-sized companies in the same sector, latest quarter on record.
Questions
What is Suraksha Diagnostic Limited's promoter holding?
Promoters held 49.10% of Suraksha Diagnostic Limited as of 30 Sep 2026, and the public held 50.90%.
Has Suraksha Diagnostic Limited's promoter holding increased?
No, it was unchanged in the quarter to Sep 2026.
Are any promoter shares of Suraksha Diagnostic Limited pledged?
No promoter shares are recorded as pledged.
How has Suraksha Diagnostic Limited's promoter holding changed over the years?
Over a longer period, promoter holding went from 48.78% in Sep 2024 to 49.10% in Sep 2026, up 0.32 points.
How does Suraksha Diagnostic Limited's promoter holding compare with similar companies?
Promoter holding in Suraksha Diagnostic Limited is lower than 66% of companies in the Healthcare sector in India. A higher or lower promoter holding is not good or bad by itself.
From the company's quarterly shareholding filings. "Public" includes institutions (foreign and domestic) and individual investors; a split by investor type is planned. ▲/▼ shows the change from the previous quarter, in percentage points. PositoAI is for research and education only and is not investment advice.